Search Results
Results found for "Dr. Bryan Roth"
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
postdoctoral training at Boston Children’s Hospital and Harvard Medical School, he joined the lab of Dr Lessons From the Front Lines of Biotech Ajay’s experience in both early-stage biotech and academic science
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Here’s what members get: Weekly deep dives from Dr.
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- 📰 GPCR Weekly News, January 30 to February 5, 2023
For Dr. GPCR News, please subscribe to your monthly newsletter. Research Fellow - School of Physics and Astronomy Postdoctoral Research Associate (Fixed Term) Explore Dr
- Why “Displacement” Misleads You: Allosteric Binding Demystified
As a member, you’ll get: Weekly expert-led lectures from Dr.
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
premium member , you can access over 500 minutes of exclusive, expert-led content from esteemed leaders, Drs
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Subscribers gain access to: Weekly lessons by Dr.
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Here ’s what members get: Weekly deep dives from Dr.
- How GPCR Collaboration Built an Innovation Engine
. 🎧 Listen to the full episode: Leadership, Luck, and GPCR Signaling 🔓 Join Dr.
- 📰 GPCR Weekly News - January 2 to 8, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- How Collaboration Drives GPCR Discoveries
. 🎧 Listen to the full conversation with Dr. David Hodson
- 📰 GPCR Weekly News, January 23 to 29, 2023
of Staff Postdoctoral Fellow, Biochemical And Cellular Pharmacology Project Leader, Biology Explore Dr
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Monthly AMAs where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.
- 📰 GPCR Weekly News - January 9 to 15, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
, you’re also unlocking over 500 minutes of exclusive, expert-led content from thought leaders like Drs
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- GPCR Buzz of the Week | Sep 23 - 29, 2024
live and work in a developing country, please complete this form to enjoy complimentary access to Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Adhesion GPCR Consortium Newsletter - May 2024
postdoctoral training, I joined one of the labs that participated in Latrophilins’ discovery, the lab of Dr
- From Student to Mentor: What Alessandro Nicoli Learned About Leading in Science
Antonella Di Pizio’s lab , there was almost nothing—no team, no culture, not even proper desks. Over the years you see the lab establishing, and for both of us, of course, growing.”
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
New scaffolds modulating the CBRs in both the orthosteric and allosteric sites have been developed, supported Their binding affinity was assessed through radioligand binding, showing a nanomolar affinity for both , both agonists and antagonists. Indeed, the difference is lower than 1pKi value between both experiments. L.; Miljuš, T.; Mexi, M.; Roth, N.; Koers, E. J.; Guba, W.; Alker, A.; Rufer, A. C.; Kusznir, E.
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
When executed as a unified pipeline, these phases ensure an HCS assay capable of supporting both exploratory Their ability to visualize ligand–receptor interactions directly in living cells produces data that are both Visual + Quantitative Data Fluorescent ligand assays generate both numerical values (IC₅₀, Kᵢ) and spatial Lin S, Schorpp K, Rothenaigner I, Hadian K. Image-based high-content screening in drug discovery.
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Studying their dynamics in both a spatial and temporal manner is key to understanding how they work in fluorescent probes must have high specificity, minimal phototoxicity and preferably be compatible with both This is why fluorescent tags, both attached to the protein or to pharmacophores, are so interesting. image stacks, facilitating the reconstruction of GPCR distribution in tissue-like environment , in both
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Dr. previously developed to bind Gαs in complex with active GPCRs, enabled detection of GLP-1R activation both
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
C GPCRs, are obligate dimers, either as homodimers or heterodimers, with distinct conformations in both Recent studies suggest that class B1 GPCRs can form both homodimers and heterodimers, which may play that GLP-1R homodimerization occurs via transmembrane helix 4 (TM4), which forms the interface for both result, dimerized SecR receptors exhibit higher rates of G protein activation and release, improving both
- Co-activation of GPCRs facilitate GIRK-dependent current
October 2022 "The activity of dopamine neurons is dependent on both intrinsic properties and afferent applications of sub-saturating concentrations of agonists where the co-application of one agonist resulted in both results suggest that the cooperative interaction between G βγ subunits and GIRK channels determines both Coincident activation of D2 and GABAB receptors leads to facilitation of GIRK channel currents, augmenting both
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
Measuring emission at both donor (usually 620nm) and acceptor (typically 665nm) wavelengths allows for Terbium is compatible with both red and green acceptors. expertise in GPCR biology with advanced fluorescence chemistry, Celtarys custom-developed ligands offer both






















